Surgery Doctors in Burleson, TX Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Wesley Marquart, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy, Suite 112, Burleson, TX 76028 Phone: 817-293-5547    Fax: 817-293-8551

Dr. Kiran Polavarapu, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 12001 South Fwy, Suite 302, Burleson, TX 76028 Phone: 817-615-8576

Maria Alejandra Martinez, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy Ste 112, Burleson, TX 76028 Phone: 817-293-5547    Fax: 817-293-8557

Dr. Alfonso Barnard Barragan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 215 Old Highway 1187, Burleson, TX 76028 Phone: 817-926-2663

News Archive

Cardiovascular disease is Europe's largest cause of death

The Council of Ministers of the European Union (EU) has acknowledged that cardiovascular disease in Europe is 'the largest cause of death of men and women in the European Union' and 'unhealthy lifestyles, particularly tobacco consumption, as well as unhealthy diet and physical inactivity amongst European citizens are risk factors to be addressed in the development of national and European policy'.

Depression in early adulthood may lead to cognitive decline in old age

While research has shown that poor cardiovascular health can damage blood flow to the brain increasing the risk for dementia, a new study led by UC San Francisco indicates that poor mental health may also take its toll on cognition.

Biothera receives approval to launch two lung cancer trials

German regulatory authorities have granted approval to Biothera to conduct two open label, multicenter, randomized Phase II clinical trials studying Imprime PGG® administered in combination with monoclonal antibodies and chemotherapy in patients with non-small cell lung cancer (NSCLC), the company announced today.

Aradigm's Lipoquin provides full protection in murine models of pneumonic plague

Scientists from the UK Defence Science and Technology Laboratory (Dstl) report, in a preliminary study, that they have demonstrated that a single dose of Aradigm Corporation's liposomal ciprofloxacin formulation Lipoquin administered 24 hours after exposure to a lethal dose of the bacterium Yersinia pestis provided full protection in a murine model of pneumonic plague.

Flexible electronic structures show potential for artificial muscles or biological tissues

Flexible electronic structures with the potential to bend, expand and manipulate electronic devices are being developed by researchers at the U.S. Department of Energy's Argonne National Laboratory and the University of Illinois at Urbana-Champaign.

Read more Medical News

› Verified 6 days ago